Research Archive — Page 42 of 139

Stylized glowing human brain surrounded by bright white-blue electrical lightning against a dark blue background.
October 16, 2023

VUMC scientists record powerful signal in the brain’s white matter

Vanderbilt researchers report that when people who are having their brains scanned by fMRI perform a task, like wiggling their fingers, certain signals increase in white matter throughout the brain, which has long been thought to play a lesser role the more the brain’s more energetic gray matter.

By Bill Snyder
October 10, 2023

Study tracks clinical team engagement with health records by patient race/ethnicity

A review of electronic health record user access logs found that EHRs of adult inpatients from minority racial and ethnic populations on average received lower engagement from health care teams than the records of white adult inpatients.

By Paul Govern
x-ray of stomach
October 5, 2023

Study validates pyrvinium as treatment to prevent stomach cancer

A Vanderbilt study found that a drug that has been used for decades for intestinal pinworms, can be repurposed as a preventative treatment for stomach cancer.

By Tom Wilemon
VUMC’s new automated biobanking system can store as many as 10 million biospecimens.
October 3, 2023

Research fellowship for genetic counselors established at Vanderbilt

Vanderbilt University School of Medicine has received a grant to establish a research fellowship for genetic counselors that will prepare them to contribute more fully to the advancement of personalized medicine.

By Bill Snyder
Sharon Kantanie, center, participated in the study of a drug that reduced soft-tissue flare-ups and the prevented new areas of abnormal bone formation. With her are, from left, Emily Shardelow, clinical/translational research coordinator; Sharon’s parents, Mary and Stan Kantanie; Margo Black, MSN, manager of research projects for Metabolic Bone Disorders; and Kathryn Dahir, MD, professor of Endocrinology and Diabetes. (photo by Erin O. Smith)
September 28, 2023

Drug trial shows reduced abnormal bone formation in those with fibrodysplasia ossificans progressiva

A Vanderbilt clinical trial evaluating the investigational drug garetosmab has shown that it reduced soft-tissue flare-ups significantly and prevented new areas of abnormal bone formation in patients with fibrodysplasia ossificans progressiva.

By Jill Clendening
Vivian Weiss, MD, PhD, center, George Xu, left, and Matthew Loberg led a multidisciplinary study that identified a molecular signature for aggressive thyroid cancer, which could help guide treatment approaches for patients. (photo by Susan Urmy)
September 25, 2023

Researchers discover molecular signature for aggressive thyroid cancer

A Vanderbilt study found that a molecular signature that predicts aggressive thyroid cancer could help guide treatment approaches for patients.

By Leigh MacMillan